DSNCARES: Promoting Weight-Loss in African American Cancer Survivors in the Deep South

Sponsor
University of Alabama at Birmingham (Other)
Overall Status
Completed
CT.gov ID
NCT03150381
Collaborator
(none)
369
1
3
71
5.2

Study Details

Study Description

Brief Summary

This study tests evidence-based strategies for weight loss among overweight and obesity cancer survivors and family members in rural Alabama.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Weight Loss Only
  • Behavioral: Weight Loss Plus
  • Behavioral: Control
N/A

Detailed Description

This is a 3-arm cluster randomized controlled study that compares a trained lay provided weight loss program vs. the same program plus community-based weight management strategies vs. general cancer prevention education on weight loss and other clinical outcomes (primary outcomes) and healthy behaviors, and psychosocial functioning (secondary outcomes).

Study Design

Study Type:
Interventional
Actual Enrollment :
369 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
Single (Participant)
Masking Description:
Single Blind (Participant)
Primary Purpose:
Prevention
Actual Study Start Date :
May 1, 2012
Actual Primary Completion Date :
Mar 31, 2018
Actual Study Completion Date :
Mar 31, 2018

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Weight Loss Only

Group-based behavioral weight loss intervention designed to reach clinically significant weight loss (~5-10% of baseline weight).

Behavioral: Weight Loss Only
24- month weight loss program (year 1: weekly in person meetings for 6 months, followed by 2 meetings per month for 3 months, then monthly for 3 months; year 2: monthly phone calls)

Experimental: Weight Loss Plus

Group-based behavioral weight loss intervention designed to reach clinically significant weight loss (~5-10% of baseline weight) plus community-level strategies to support healthy weight. Strategies are based on CDC's recommended community strategies and are developed by local contractors. They include expanded farmers markets/gardens, improvement to walking trails, etc.

Behavioral: Weight Loss Plus
Participants will attend in-person weekly sessions (about 1.5 hours each) for 6 months and then twice a month for 3 months and monthly for 3 months. Sessions focus on behavioral techniques supporting healthy diet (including calorie restriction for weight loss) and achieving recommended amounts of physical activity per week. During 1-year weight loss maintenance, participants receive monthly motivational phone calls.

Active Comparator: Control

Educational materials and optional participation in community-wide cancer awareness activities.

Behavioral: Control
Participants receive quarterly newsletters containing generic cancer prevention messages and participate in community-wide cancer awareness educational sessions.

Outcome Measures

Primary Outcome Measures

  1. Weight [Baseline to 6 months]

    Measured weight (nearest kg)

Secondary Outcome Measures

  1. Waist Circumference [Baseline to 24 months]

    Measured circumference (nearest cm)

  2. Lipids [Baseline to 24 months]

    Measured total cholesterol, triglycerides, HDL, LDL, ratio (mg/dL)

  3. Blood Pressure [Baseline to 24 months]

    Measured blood pressure (mmHG) - systolic and diastolic

  4. Weight [Baseline to 12 months]

    Measured weight (nearest kg)

  5. Weight [Baseline to 24 months]

    Measured weight (nearest kg)

  6. Social Support for Diet and Exercise Behaviors [Baseline to 6 months]

    self report measure of social support (family, friend) in performing diet and exercise behaviors

  7. Social Support for Diet and Exercise Behaviors [Baseline to 12 months]

    self report measure of social support (family, friend) in performing diet and exercise behaviors

  8. Social Support for Diet and Exercise Behaviors [Baseline to 24 months]

    self report measure of social support (family, friend) in performing diet and exercise behaviors

  9. Self Efficacy for Diet and Exercise Behaviors [Baseline to 6 months]

    self report measure of confidence in performing diet and exercise behaviors

  10. Self Efficacy for Diet and Exercise Behaviors [Baseline to 12 months]

    self report measure of confidence in performing diet and exercise behaviors

  11. Self Efficacy for Diet and Exercise Behaviors [Baseline to 24 months]

    self report measure of confidence in performing diet and exercise behaviors

  12. Automated Self-Administered 24-Hour Dietary Assessment Tool (ASA24) [Baseline to 6 months]

    self report measure of dietary intake

  13. Automated Self-Administered 24-Hour Dietary Assessment Tool (ASA24) [Baseline to 12 months]

    self report measure of dietary intake

  14. Automated Self-Administered 24-Hour Dietary Assessment Tool (ASA24) [Baseline to 24 months]

    self report measure of dietary intake

Eligibility Criteria

Criteria

Ages Eligible for Study:
19 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • African American breast, colon, or prostate cancer survivor (Index Participant)

  • Family member (support person) of African American breast, colon, or prostate cancer survivor (Family Member Participant)

  • Live, work, or attend school in target county

  • BMI >= 25 kg/m2

Exclusion Criteria:
  • Pregnant or planning to become pregnant in the next year

  • Known major medical or psychological condition known to influence body weight

  • Uncontrolled hypertension (BP > 160 mmHg systolic or >100 mmHg diastolic)

  • medicated or poorly controlled diabetes (glucose > 126) Cardiovascular event in the preceding 12 months

  • History of gastric bypass or bariatric surgery

  • History of psychiatric hospitalization in past 2 years

  • History of substance abuse or eating disorder

  • Any other condition by which a medical professional has suggested diet modification, physical activity and/or weight reduction would be contraindicated

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Alabama at Birmingham Birmingham Alabama United States 35294

Sponsors and Collaborators

  • University of Alabama at Birmingham

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Monica L Baskin, Principal Investigator, University of Alabama at Birmingham
ClinicalTrials.gov Identifier:
NCT03150381
Other Study ID Numbers:
  • X120329018
First Posted:
May 12, 2017
Last Update Posted:
May 16, 2018
Last Verified:
May 1, 2018
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 16, 2018